$242 Million is the total value of Atlas Venture Advisors, Inc.'s 6 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CBLK | CARBON BLACK INC | $164,242,000 | +19.9% | 9,823,103 | 0.0% | 67.98% | -1.7% | |
| TBIO | TRANSLATE BIO INC | $49,535,000 | +23.9% | 3,922,008 | 0.0% | 20.50% | +1.6% | |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $13,709,000 | – | 1,362,696 | +100.0% | 5.67% | – |
| MGEN | MIRAGEN THERAPEUTICS INC | $6,442,000 | -26.5% | 3,142,580 | 0.0% | 2.67% | -39.8% | |
| ZFGN | ZAFGEN INC | $4,172,000 | -56.6% | 3,506,207 | 0.0% | 1.73% | -64.4% | |
| SNAP | SNAP INCcl a | $3,505,000 | +29.8% | 245,076 | 0.0% | 1.45% | +6.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SNAP INC | 20 | Q3 2023 | 6.1% |
| ROKU INC | 16 | Q3 2023 | 11.7% |
| LARIMAR THERAPEUTICS INC | 14 | Q3 2023 | 1.4% |
| TRANSLATE BIO INC | 11 | Q2 2021 | 52.9% |
| INTEGRAL AD SCIENCE HLDNG CO | 10 | Q3 2023 | 71.2% |
| BICYCLE THERAPEUTICS PLC | 10 | Q3 2021 | 25.2% |
| VIRIDIAN THERAPEUTICS INC | 10 | Q1 2023 | 2.1% |
| F-STAR THERAPEUTICS INC | 9 | Q4 2022 | 1.3% |
| DRAFTKINGS INC | 8 | Q1 2022 | 82.5% |
| MIRAGEN THERAPEUTICS INC | 8 | Q3 2020 | 5.0% |
View Atlas Venture Advisors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-01-27 |
| 13F-HR | 2021-11-04 |
View Atlas Venture Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.